Replacing sugary drinks with water can also reduce overall calorie intake
Robert Popovian 11:29 Rekha is one of those individuals that really understands how to build a coalition on the ground with patients and providers, and lets hear from her right now
Patients often experience improvements in Energy levels Blood sugar control Mobility Blood pressure Confidence Physical fitness Overall quality of life Celebrating these non-scale victories helps maintain motivation throughout the journey
Am J Cardiol 99:27B40B Sertznig P, Seifert M, Tilgen W, Reichrath J (2008) Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases
2 for T2DM and obesity from known GLP-1R agonists Eli Lilly corporate presentation Eli Lilly, Indianapolis, IN Eli Lilly has disclosed the structure of its next-generation small molecule GLP-1R agonist, naperiglipron (LY3549492), at a pivotal moment for the class
citalopram, fluoxetine, sertraline (anxiety and depression) Drugs metabolised by CYP450 2D6: Codeine (opioid painkiller) Inducers CYP450 2C19: Rifampicin (TB) Carbamazepine (epilepsy, trigeminal neuralgia) Inhibitors CYP450 2C19: Lansoprazole, omeprazole (reflex and heartburn) Drugs metabolised by CYP450 2C19: Warfarin (anticoagulant) Diazepam (sedative, anxiolytic) Phenytoin (epilepsy) Inducers CYP450 2C9: Rifampicin (TB) Carbamazepine (epilepsy, trigeminal neuralgia) Inhibitors CYP450 2C9: Miconazole (antifungal) Fluconazole (antifungal) Drugs metabolised by CYP450 2C9: Warfarin (anticoagulant) Non-steroidal anti-inflammatories Clopidogrel (antiplatelet) Genetical variations Genetic variations can lead to altered CYP450 polymorphisms and so altered metabolism of drugs
